Mark Gustavson

Company: AstraZeneca

Job title: Senior Director & Global Head of Computational Pathology & Translational Science

Seminars:

Computational Pathology – The Next Revolution in Cancer Diagnostics for Drug Development 9:00 am

Computational Pathology provides greater analytical precision and potentially greater clinical accuracy enabling identification of best patients populations for clinical response to oncology therapies Quantitative Continuous Scoring (QCS) was developed to both quantify target expression in individual tumour cells and to quantify spatial heterogeneity of expression We will discuss how we are leveraging Computational Pathology approaches…Read more

day: Day One